Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity

Although tumor‐specific neoantigen‐based cancer vaccines hold tremendous potential, it still faces low cross‐presentation associated with severe degradation via endocytosis pathway. Herein, a thiolated nano‐vaccine allowing direct cytosolic delivery of neoantigen and Toll like receptor 9 agonist CpG...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Da, Lin, Ziguo, Wu, Ming, Cai, Zhixiong, Zheng, Youshi, He, Lei, Li, Zhenli, Zhou, Jie, Sun, Liqin, Chen, Geng, Zeng, Yongyi, Li, Juan, Liu, Jingfeng, Yang, Huanghao, Liu, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967047/
https://www.ncbi.nlm.nih.gov/pubmed/33747739
http://dx.doi.org/10.1002/advs.202003504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967047/
https://www.ncbi.nlm.nih.gov/pubmed/33747739
http://dx.doi.org/10.1002/advs.202003504

Ejemplares similares